| Literature DB >> 32481241 |
Alshimaa R Αzab1,2, Ragab K Elnaggar1,2, Reham H Diab3,4, Samah A Moawd2,5.
Abstract
OBJECTIVE: This study evaluated whether the use of kinesio taping (KT) would enhance the effect of physical therapy in relieving pain, improving muscle endurance, and boosting functional capacity in adolescents with hemophilia who experience low back pain.Entities:
Keywords: Endurance; Functional Capacity; Hemophilia; Kinesio Taping; Low Back Pain
Mesh:
Year: 2020 PMID: 32481241 PMCID: PMC7288385
Source DB: PubMed Journal: J Musculoskelet Neuronal Interact ISSN: 1108-7161 Impact factor: 2.041
Figure 1Participants’ flow diagram.
Baseline descriptive statistics of the study groups.
| KT group (n=15) | Placebo group ( | Control group ( | ||
|---|---|---|---|---|
| Age, | 11.80 ± 0.94 | 11.33 ± 1.32 | 12.13 ± 0.83 | .11 |
| Weight, | 35.67 ± 3.83 | 36.13 ± 3.72 | 37.47 ± 3.34 | .38 |
| Height, | 1.35 ± 0.06 | 1.34 ± 0.07 | 1.37 ± 0.06 | .57 |
| BMI, | 19.43 ± 0.83 | 19.98 ± 1.20 | 20.02 ± 0.90 | .21 |
| Bleedings in last 12 months, | 1 (0 – 2.4) | 2 (0.6 – 3) | 2 (0 – 3.4) | .08 |
| Pain medication usage (never/occasional/frequent), | 6/8/1 | 8/5/2 | 10/3/2 | .47 |
| Factor replacement (prophylaxis/on-demand), | 5/10 | 7/8 | 6/9 | .93 |
| Duration of lower back pain, | 92.53 ± 33.12 | 84.47 ± 30.02 | 102.27 ± 21.92 | .25 |
Data expressed as mean ± SD, bleedings in last 12 months expressed as median (10-90 percentile), BMI: body mass index.
Visual analogue pain scores for the study groups.
| KT group ( | Placebo group ( | Control group ( | |||
|---|---|---|---|---|---|
| Pre | 6.93 ± 1.07 | 6.54 ± 0.97 | 7.33 ± 0.72 | 2.568 | .09 |
| Post | 4.43 ± 1.28 | 5.23 ± 0.73 | 6.13 ± 1.36 | 7.696 | .002 |
| 6.009 | 3.157 | 3.154 | |||
| <.001[ | .008[ | .007[ | |||
| Cohen’s | 1.61 | 0.87 | 0.81 |
Data expressed as mean ± SD,
significant ANOVA test (between-group difference),
significant paired t-test (within-group difference).
Figure 2Proportion of adolescents with post-treatment pain levels changed to ≤5 versus those with ongoing pain >5 in the study groups.
Mean endurance time (seconds) of lower back muscles in the Biering-Sorensen test for the study groups.
| KT group ( | Placebo group ( | Control group ( | |||
|---|---|---|---|---|---|
| Pre | 76.93 ± 13.44 | 74.31 ± 15.52 | 83.27 ± 12.91 | 1.553 | .22 |
| Post | 96.64 ± 10.48 | 82.38 ± 14.10 | 86.47 ± 7.89 | 6.140 | .005 |
| -10.223 | -2.324 | -1.436 | |||
| <.001[ | .039[ | .17 | |||
| Cohen’s | 2.73 | 0.64 | - |
Data expressed as mean ± SD,
significant ANOVA test (between-group difference),
significant paired t-test (within-group difference).
Figure 3Distance covered in the 6-minute walk test (m) in the study groups at the baseline (4-A) and post-treatment (4-B).